相关实验视频
Updated: Jun 16, 2026
07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.5K
了解肥胖患者对代谢性减肥手术的偏好:基于选择的全面适应性联合分析
Doaa Hussein Hassan Dewedar1, Ehsan Akram Ahmed Deghidy2, Mohamed Hany3
1Biomedical Informatics and Medical Statistics, Medical Research Institute, Alexandria University, Ministry of Health, Alexandria, Egypt.
概括
寻求代谢性减肥手术 (MBS) 的患者优先考虑显著的减肥和最小的并发症. 影响决策的关键因素包括预期的体重减轻,并发症风险和副作用,而不是初始成本.
科学领域:
- 肥胖医学 肥胖医学
- 手术创新 在外科创新.
- 以患者为中心的护理
背景情况:
- 患者对代谢性减肥手术 (MBS) 的偏好尚未得到充分了解.
- 关于MBS候选人的决策因素的数据有限.
研究的目的:
- 识别和分析影响患者对代谢性减肥手术 (MBS) 决策的关键因素.
- 在手术减肥的背景下了解患者的优先事项.
主要方法:
- 基于自适应选择的联合分析被用来评估患者的偏好.
- 一项在线调查收集了社会人口统计数据和患者对手术特征的选择.
- 包括299名在专门诊所接受MBS的患者.
主要成果:
- 患者高度重视实现80%的体重减轻,没有复发 (14.67),没有并发症风险 (13.74),没有不良影响 (11.32).
- 两组患者出现了:那些优先考虑减肥的人和那些优先考虑避免并发症的人.
- 最初的成本和医疗状况的解决方案的影响较小.
结论:
- 代谢性减肥手术候选人优先考虑长期减肥和安全,而不是立即的成本.
- 患者对MBS的决策主要取决于预期的结果和降低风险.
- 了解这些偏好可以优化外科咨询和患者选择.
相关概念视频
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...